The pharmacologic effects of beta 2-adrenoceptor agonist drugs, including vilanterol ... and treat if paradoxical bronchospasm occurs; use alternative therapy. Cardiovascular disease (esp.

Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US) is GSK’s follow up to its respiratory blockbuster Advair/Seretide, but won’t come close to ...

Now, it has decided to publish a special report on two of GSK's COPD therapies – Breo Ellipta ... of the two drugs compared to their respective fixed-dose generic alternatives or open generic ...